EYE DISORDERS CONGENITAL
Clinical trials for EYE DISORDERS CONGENITAL explained in plain language.
Never miss a new study
Get alerted when new EYE DISORDERS CONGENITAL trials appear
Sign up with your email to follow new studies for EYE DISORDERS CONGENITAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to halt blindness in rare genetic eye disorder
Disease control Recruiting nowThis study tests a drug called ultevursen in 81 people with retinitis pigmentosa caused by a specific gene change (USH2A). The drug is injected into the eye and compared to a sham injection. The goal is to see if it can slow the loss of vision over two years. Participants must be…
Matched conditions: EYE DISORDERS CONGENITAL
Phase: PHASE2 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated May 26, 2026 09:42 UTC
-
Experimental eye drug aims to restore sight in rare genetic blindness
Disease control Recruiting nowThis study tests an experimental drug called sepofarsen in people with a rare genetic eye disease (LCA10) that causes severe vision loss from childhood. The drug is injected into one eye, while the other eye gets a placebo, to see if it can improve vision safely. About 32 partici…
Matched conditions: EYE DISORDERS CONGENITAL
Phase: PHASE3 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated May 26, 2026 09:29 UTC